Share
Our Company
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter/Full-Year 2016 Results
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter/Full-Year 2016 Results
Share

NEW BRUNSWICK, N.J., Dec. 27, 2016 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, Jan. 24th, to review fourth-quarter and full-year results.  Alex Gorsky, Chairman and Chief Executive Officer; Dominic Caruso, Executive Vice President, Chief Financial Officer and Joseph J. Wolk, Vice President, Investor Relations, will host the call.

Investors and other interested parties can access the webcast/conference call in the following ways:

  • The webcast is accessible at Johnson & Johnson's website: www.investor.jnj.com. A webcast and podcast replay will be available approximately three hours after the conference call concludes.
  • By telephone: for both "listen-only" participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 877-869-3847. For participants outside the U.S., the dial-in number is 201-689-8261.
  • A replay of the conference call will be available until approximately 12:00 a.m. on Feb. 1, 2017. The replay dial-in number for U.S. participants is 877-660-6853. For participants outside the U.S., the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13651932.
  • The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call.

About Johnson & Johnson
Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 126,900 employees at more than 250 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

SOURCE Johnson & Johnson

  • Press - Ernie Knewitz, (732) 524-6623, (917) 697-2318 (M), or Amy Jo Meyer, (732) 524-6678, (908) 616-6250 (M), or Investors - Joseph J. Wolk, (732) 524-1142, or Lisa Romanko, (732) 524-2034
This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue